Tenderwize
Wróć do wyszukiwania

Open house discount agreements for Secukinumab

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 186 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Secukinumab, ATC L04AC10

40/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

40 / 100

Złożoność

20 / 100

Czynniki ryzyka

The buyer reserves the right to replace open-house contracts with exclusive contracts from separate tenders, which woul...

No estimated value or volume guarantees; actual uptake depends on prescribing behavior and number of participants.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Supply of Secukinumab (ATC L04AC10) pharmaceutical products
  • Enter into non-exclusive discount agreements with AOK Rheinland-Pfalz/Saarland
Pokaż pełne podsumowanie

Open House non-exclusive discount agreement for Secukinumab (ATC L04AC10) by AOK Rheinland-Pfalz/Saarland. The procedure is open for all interested pharmaceutical companies to enter into discount contracts under uniform conditions. The contract term is max 24 months starting 01.05.2025, with rolling entry on the first of each month. The notice explicitly states it is not a public procurement under EU directive 2014/24/EU.

Ryzyka

The buyer reserves the right to replace open-house contracts with exclusive contracts from separate tenders, which woul...

No estimated value or volume guarantees; actual uptake depends on prescribing behavior and number of participants.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Only authorized and marketable drugs in Germany may be supplied
  • For drugs not yet in Lauer-Taxe: provide AMIce database extract with proof of authorization and marketability

Administrative

  • Submission of signed contract documents

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria specified; this is an open-house model with no selection.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open house discount agreements for Secukinumab

Non-exclusive discount contracts for Secukinumab (ATC L04AC10). All interested pharmaceutical companies can participate under uniform terms. Contracts are non-exclusive and may be replaced by exclusive contracts from separate tenders. Maximum duration 24 months from earliest start date (01.05.2025).

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

Apr 2025 - Apr 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria specified; this is an open-house model with no selection.

Termin

Deadline Feb 28, 2027

Szczegóły zamówienia

Data publikacji
12 Mar 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
162068-2025

Dokumenty (1)

Podobne przetargi